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Abstract
Background: Foot musculoskeletal deficits are seldom addressed by preventive medicine despite their high
prevalence in patients with diabetic polyneuropathy.
AIM: To investigate the effects of strengthening, stretching, and functional training on foot rollover process during
gait.
Methods: A two-arm parallel-group randomized controlled trial with a blinded assessor was designed. Fifty-five
patients diagnosed with diabetic polyneuropathy, 45 to 65 years-old were recruited. Exercises for foot-ankle and gait
training were administered twice a week, for 12 weeks, to 26 patients assigned to the intervention group, while 29
patients assigned to control group received recommended standard medical care: pharmacological treatment for
diabetes and foot care instructions. Both groups were assessed after 12 weeks, and the intervention group at
follow-up (24 weeks). Primary outcomes involved foot rollover changes during gait, including peak pressure (PP).
Secondary outcomes involved time-to-peak pressure (TPP) and pressure–time integral (PTI) in six foot-areas, mean
center of pressure (COP) velocity, ankle kinematics and kinetics in the sagittal plane, intrinsic and extrinsic muscle
function, and functional tests of foot and ankle.
Results: Even though the intervention group primary outcome (PP) showed a not statistically significant change
under the six foot areas, intention-to-treat comparisons yielded softening of heel strike (delayed heel TPP, p=.03),
better eccentric control of forefoot contact (decrease in ankle extensor moment, p<.01; increase in function of ankle
dorsiflexion, p<.05), earlier lateral forefoot contact with respect to medial forefoot (TPP anticipation, p<.01), and
increased participation of hallux (increased PP and PTI, p=.03) and toes (increase in PTI, medium effect size). A
slower COP mean velocity (p=.05), and an increase in overall foot and ankle function (p<.05) were also observed.
In most cases, the values returned to baseline after the follow-up (p<.05).
Conclusions: Intervention discreetly changed foot rollover towards a more physiological process, supported by
improved plantar pressure distribution and better functional condition of the foot ankle complex. Continuous
monitoring of the foot status and patient education are necessary, and can contribute to preserving the integrity of
foot muscles and joints impaired by polyneuropathy.
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Background
The increased risk of plantar ulceration in patients with
diabetic polyneuropathy (DPN) is often associated with a
heterogeneous plantar pressure distribution character-
ized by overloading of anterior regions, unloading of
toes and hallux [1-6], and a reduced role of lateral fore-
foot and toes in the foot rollover during stance phase
[7]. This loading pattern is a result of alterations in the
foot rollover process during walking [7-9], following an
overall worsening of foot-ankle muscular, articular and
nervous function.
From a biomechanical point of view, the main normal
foot functions during walking are to dampen down heel
stress by reducing excessive impulse loading upon initial
contact, adapt to the instantaneous changes in contact
surface during midstance, and provide stability during
propulsion [10,11]. As DPN progresses, the integrity is
affected of the muscles and neural structures [12,13]
mostly of the small joints of the foot and ankle [8],
which restricts the proper load absorption and manage-
ment in the gait stance phase. Sustained hyperglycemia
causes additional structural alterations which affect the
physiological gait biomechanics —impaired tropism and
activation of muscles—which interfere with the quality
and control of movement, drastically affecting load ab-
sorption and transmission during the foot rollover
process [14,15]. More specifically, Tibialis anterior weak-
ness could potentially contribute to higher peak pres-
sures [16-18], and the resulting atrophy of the small
intrinsic foot muscles [19,20] could compromise the
static and dynamic stability of foot rollover.
Unfortunately, there is still no efficient and definitive
intervention to manage this epidemic, chronic complica-
tion (DPN), which highlights the relevance of studying
complementary and synergistic treatments and/or re-
inforcing preventive actions. DPN is an insidious, long-
term complication, thus preventive actions are essential
in the care of the population with diabetes.
Since higher peak pressure values have been correlated
with an increased incidence of plantar ulceration [1,2],
the reduction of tissue stress has been established as one
of the main goals of interventions in DPN patients. Off-
loading techniques have been extensively explored in the
literature, in particular under the form of custom-made
footwear, insoles, and orthotic devices. The effectiveness
of this approach, however, is hard to confirm: standardi-
zation is lacking and the application of the appropriate
techniques is not always assured [21,22], not to speak
of the very low adherence to this type of treatment
[23].
Offloading devices, whose main target is to redistrib-
ute plantar loads by acting as an external device at the
interface between the foot and the ground, may passively
induce, as a minor consequence, some changes in the
musculoskeletal control of the foot rollover. Conversely,
foot and ankle exercises have the main aim, and the
benefit, of changing the foot rollover actively as a major
consequence of their being performed on a regular basis,
thereby promoting a proper musculoskeletal response,
i.e. absorbing and transmitting loads as the body moves
forward during walking.
Few authors have described the subtle, positive effects
of foot and ankle exercises in this population, although
some studies were not randomized controlled trials
[24,25], and others reported on quite short interventions
and follow-up periods [26,27]. Therefore, there are still
not enough data for conclusions to be arrived at regard-
ing the effectiveness of such interventions.
The present study describes the outcomes of a ran-
domized, controlled trial to describe the effects of active
stretching, strengthening, balance, and walking exercises
[28] on the foot rollover process of DPN patients with
no previous episode of plantar ulceration.
The main hypothesis of the study was that a phy-
siotherapeutic intervention would improve the foot roll-
over process and successfully redistribute dynamic
plantar loading. The complex dynamic process of foot
rollover is hardly representable by means of a single
variable, but it can be described by a combination of
plantar pressure variables such as peak pressure, pres-
sure–time integral, center of pressure trajectory and vel-
ocity. We chose peak pressure as the primary outcome
because it is the most commonly described one for the
population investigated [1,29-31]. However, the descrip-
tion of foot rollover process was also accomplished using
other related biomechanical (kinetic and kinematic pa-
rameters) and clinical variables hereby referred as sec-
ondary outcomes.
The clinical relevance of this study relies on the as-
sumption that this specific intervention could lead to
the recovery of muscle and joint function in patients
with DPN, and enable them to maintain, for as long as
possible, the residual capability to interact safely with
the ground while walking or standing.
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Methods
The clinical trial was approved by the local Ethics Com-
mittee (Comitê de Ética em Pesquisa da Faculdade de
Medicina da Universidade de São Paulo, protocol num-
ber 054/10). All patients gave their written informed
consent according to the standard forms. The study
started in August 2010 but the recruitment period lasted
from October 2010 to August 2012.
Setting and participants
The eligibility criteria were: patients 45–65 years of age;
diabetes mellitus type 1 or 2; diagnosed for at least seven
years; body mass index ranging 18.5–29.9 kg/m2 (normal
and overweight classifications); DPN diagnosed by the
medical care center; score higher than 2 out of a max-
imum of 13 points in the Michigan Neuropathy Screen-
ing Instrument (MNSI) questionnaire [32], indicating
the presence of at least two DPN symptoms; score
greater than 1 point on a 10 point scale for physical as-
sessment according to the MNSI instrument, but always
including impaired vibration perception; ability to walk
independently in the laboratory; without any episode of
plantar ulceration no partial or total foot amputation;
and not receiving any physiotherapy intervention or off-
loading devices. Patients were not included if they had
other neurological or orthopedic impairments, major
vascular complications, severe retinopathy, or severe
nephropathy.
The baseline characteristics of the participants are
provided in Table 1.
The participants were recruited from three settings: (a)
a diabetes mellitus ambulatory medical care located in a
regional hospital, (b) the National Association of Dia-
betes (ANAD), and (c) a primary care center at the
School of Medicine of the University. Candidates for re-
cruitment were interviewed on the telephone. If selected,
they went through a first assessment to confirm the eli-
gibility criteria. This first assessment was taken as the
baseline condition. The physical therapist who per-
formed all the clinical assessments was blinded to the
groups.
The patients allocated to the intervention group were
treated in the Physical Therapy Department of the Uni-
versity, in a real ambulatory setting.
Design overview
A two-arm, parallel-group randomized controlled trial
was designed. The patients allocated to the intervention
group (IG) received physical therapy and instructions to
perform exercises at home; the control group (CG)
received neither. Both groups were assessed at baseline
and after 12 weeks. The IG was further assessed at week
24 (follow-up period). Initially, we planned to implement
a crossover arm for the CG in order to achieve the sample
size as early as possible [28]. Unfortunately, there was a
high incidence of non-adherence of these patients to re-
ceive intervention after the 12 weeks, and the crossover
intervention could not be implemented. Only 8 out of the
29 patients initially allocated to CG, confirmed their inter-
est in receiving intervention after 12 weeks. Because of
this low adherence and the ensuing cancellation of the
crossover arm, it was not possible to assess the CG to-
gether with the IG in the follow-up evaluation. The final
design of the study is presented in Figure 1.
Randomization and interventions
The randomization schedule was done with Clinstat
software [33] by an independent researcher, who was not
aware of group codes. A numeric block randomization
sequence, with blocks varying randomly in size from one
to eight, was kept in sequentially numbered, opaque en-
velopes. After an initial assessment for compliance with
Table 1 Baseline demographic and clinical characteristics of each group
Control Group (n = 29) Intervention Group (n = 26) p (T-test) p (Mann–Whitney)
Age (years) 60 (12) 59 (4) 0.40 -
Sex (% female) 52 42 - 0.34
Time of onset of diabetes (years) 18 (11) 17 (10) 0.81 -
Type 2 diabetes (%) 92.9 96.9 - 0.85
Fasting blood glucose (mg/dL) 166.7 (98.6) 157.6 (89.8) 0.60 -
Body mass (kg) 82.5 (16.4) 77.4 (14.1) 0.24 -
Height (m) 1.71 (0.30) 1.65 (0.09) 0.30 -
BMI (kg/m2) 29 (4) 28 (4) 0.54 -
Insulin intake (%) 60 50 - 0.61
Practice regular physical activity 33% 42% -
MNSIa questionnaire (median) 6 [3;8] 6 [4;8] - 0.59
MNSIa physical assessment (median) 4.5 [3.0;6.5] 4.5 [3.0;6.5] - 0.62
aMichigan Neuropathy Screening Instrument.
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eligibility criteria, patient enrollment was conducted by a
physical therapist who also performed all the blind as-
sessments. If a patient agreed to participate in the study,
allocation to a group was made by a second independent
researcher, unaware of group codes. Only the physio-
therapist who administered the intervention did know
who should receive it.
The intervention - 40–60 minutes per session, twice a
week, for 12 weeks - started as soon as the patient was
allocated to the IG. The therapeutic session was divided
into four blocks of exercises with the following aims: (a)
increase foot and ankle range of motion, (b) strengthen
foot and ankle muscles, (c) increase foot and ankle per-
formance through functional exercises, and (d) increase
walking skills and foot rollover training. Each session in-
cluded a selection of exercises from each of the four ex-
ercises groups. The patient was exposed to gradual and
progressive difficulty; attention was paid to pain and/or
performance deterioration during execution. In each ses-
sion, the exercises followed a sequence that started with
passive exercises, progressed to active ones, and finished
with walking and functional skills. Therefore, the motor
integration of peripheral gains into functional movements
could be optimized during each session. The complete
intervention protocol is described in Additional file 1:
Table S1 and has been published elsewhere [28]. Some im-
ages of the exercises are shown in Additional file 2: Figure
S2 that were available by a written informed consent pro-
vided by the patients.
The CG did not receive any Physical Therapy inter-
vention or any instruction to perform exercises at home
during the same period, but continued to receive cus-
tomized medical care, which included pharmacological
treatment for diabetes and foot care instructions as rec-
ommended by Bakker et al. [34]. The dropouts and de-
clines are described in the flow chart of the participants
(Figure 1).
Apart from intervention exercises, neither group chan-
ged the amount of physical activity after the beginning
of the study.
Assessed for eligibility
(n=177)
Not included (n=122)
Did not meet eligibility criteria (n=110)
Declined to participate (n=12)
Randomized (n=55)
Allocated to intervention (n=26)
Received intervention (n=22)
Did not receive intervention (n=4):
- 3 lost contact without giving reasons
- 1 broken rib due to fall
Lost to second assessment (n=4):
- 1 interrupted to treat lower limb edema
- 3 interrupted for distance problems
Allocated to control group (n=29)
Completed the period (n=25)
Did not complete the period (n=4)
Total analyzed (n=26)
Excluded from analysis (n=0)
Lost to second assessment (n=4):
- 1 interrupted to treat sciatic pain
- 1 interrupted for gallbladder surgery
- 1 moved from city
- 1 lost contact without giving reasons
Total analyzed (n=29)
Excluded from analysis (n=0)
Lost to followup (n=1)
- 1 heart attack
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Figure 1 Flow of participants through the trial.
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Primary outcomes
Although the foot rollover process during gait may be
represented by a combination of plantar loading vari-
ables, we chose peak pressure (PP) over plantar surface
as primary outcome. For the purpose of sample size cal-
culation, the peak pressure under the lateral forefoot
was chosen because it is typically one of the main foot
areas that present alterations due to DPN [7] and has
been demonstrated to be different substantially from
healthy individuals [31].
Secondary outcomes
The secondary outcomes were grouped in three sets: (1)
additional loading variables representing foot rollover;
(2) kinematic and kinetic variables of the ankle joint; (3)
clinical outcomes.
The loading variables were: (a) mean velocity of the
total trajectory of the center of pressure (COP), which
indicates how fast the body moves over the foot, (b) time
to peak pressure (TPP), which detects whether the con-
tact of a specific foot area is anticipated or delayed after
the intervention, (c) pressure–time integral (PTI) over
six plantar areas (heel, midfoot, lateral and medial fore-
foot, hallux and toes).
The kinematic and kinetic outcomes of the ankle joint
were: (a) the total sagittal range of motion during the
stance phase of gait (degrees), (b) the joint angle (sagittal
plane) at the end of the propulsion phase (degrees), (c)
the peak of extensor and flexor moments at approxi-
mately 20% and 80% of the stance phase of gait (% body
weight* height), corresponding to the flattening of the
foot and the beginning of propulsion, respectively.
The clinical outcomes were: (a) foot and ankle muscle
function, (b) functional tests for foot and ankle, (c)
scores of Michigan Neuropathy Screening Instrument
(MNSI questionnaire and foot physical assessment) [32],
(d) the score for the Activities-specific Balance Confi-
dence (ABC) Scale [35].
Data acquisition of all outcomes and mathematical
analysis of the biomechanical outcomes
Loading variables
Plantar pressure distribution was recorded using the
Pedar-X System (Novel, Munich, Germany) at 100 Hz.
The patients walked barefoot on a 10 m walkway at a
self-selected cadence resulted within 96–116 steps/min
(normal gait cadence) [36], with the insole placed and
fixed, using anti-skid socks fixed with a stripe around
the ankle. Twenty five valid steps per foot (the middle
steps of 4 trials) were acquired and analyzed for each pa-
tient. The plantar pressure data (PP, PTI, and COP mean
velocity) were calculated for 6 areas of interest (heel,
midfoot, medial forefoot, lateral forefoot, hallux and
toes) using the software Novel-projects (Novel, Munich,
Germany). The plantar surface was first divided into three
larger areas: rearfoot (27% of foot length), midfoot (28% of
foot length), and forefoot and toes (45% of foot length).
The forefoot was subdivided in width into: medial forefoot
(55% of the forefoot width) and lateral forefoot (45% of
the forefoot width). The forefoot was also subdivided in
length into: hallux (the final 20% of foot length with 33%
of width) and toes (the final 20% of foot length with 67%
of width). TPP was calculated in a custom-written
MATLAB function from the peak pressure temporal
series as the instant of peak occurrence relative to stance
duration (also for the same 6 foot areas).
Kinematic and kinetic outcomes
The kinematics of retro-reflective markers, with attach-
ment locations based on the Cleveland protocol [37],
were recorded at 100 Hz by six infrared cameras (2D ac-
curacy < 2 mm) (OptiTrack FLEX: V100, Natural Point,
Corvallis, OR, USA) [38] using AMASSTM software (C-
Motion, USA). Ground reaction force data were ac-
quired at 100 Hz by means of a strain gauge force plate
(AMTI OR-6 – 1000, Watertown, MA, USA). For the
ground reaction force and kinematic data acquisition,
patients walked barefoot, at the same walking cadence
established at plantar pressure trials, and ten valid trials
were acquired and analysed for each patient. The kine-
matic and ground reaction force data were synchronized
and sampled at 100 Hz by an A/D card (AMTI, DT
3002, 12 bits). Data were filtered with low pass filter
Butterworth of 4th order at 20 Hz for force data and
6 Hz for kinematics. The bottom-up inverse dynamic
method was used for calculating the net ankle moment.
The human body was modeled by three linked segments
(foot, shank and thigh), and the anthropometric parame-
ters were adopted from Dempster & Gaughran [39].
Mathematical analyses of the kinematic and ground reac-
tion force data were performed using Visual3D software
(C-motion, Kingston, ON, Canada), and the net ankle mo-
ment of force was calculated in a custom-written Matlab
function (MathWorks, Natick, MA, USA).
Clinical outcomes
All the clinical assessments were performed by a physio-
therapist who was blind to group allocation. They in-
cluded anamnesis for personal details and diabetes
history, MNSI scores and ABC score.
Intrinsic and extrinsic foot and ankle muscle functions
were assessed with manual function testing [40,41], as
there is currently no available instrument capable of
measuring the functions of tested muscles. The assessed
muscles were triceps surae, tibialis anterior, interosseous,
lumbrical, flexor hallucis brevis, flexor digitorum brevis,
extensor hallucis longus and brevis, and extensor digi-
torum longus and brevis.
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For the evaluation of the feet and ankle function, we
used functional tests based on Magee et al. (1997), in
which the patients were asked to perform the following
movements: ankle flexion and extension in one leg
stance and toes flexion and extension in sitting position.
Patients were asked to repeat each movement as fast as
possible for 30 seconds, without compensating the
movements. Classification was according to the follow-
ing scale: 0 repetitions: not functional; 1–4 repetitions:
barely functional; 5–9 repetitions: reasonably functional;
10–15 repetitions: functional.
Statistical analysis
Sample size was calculated on the basis of the primary
outcome (PP at the lateral forefoot) and was accom-
plished using a moderate effect size (f = 0.36). Standard
deviation estimates were taken from one of the authors’
previous studies, wherein a similar patient cohort had
been recruited [42]. A sample size of 46 subjects initially
was calculated to detect a moderate effect difference be-
tween the highest and lowest group pressure means,
with a power of 81%, an alpha level of 0.05, a statistical
design of F test of repeated measures (between and
within effects), and assuming a 10% loss to follow-up.
The actual loss of the study was of 15.6% of patients;
sample size was, therefore, recalculated and a total of 55
patients were recruited to warrant sample power.
An intention-to-treat analysis was performed. The
missing data was treated as missing completely at ran-
dom (MCAR) [43], using the ‘mean of series’ imputation
method [44] for the values with normal distribution
(TPP, PP, PTI, mean COP velocity, kinetic and kinematic
variables, MNSI questionnaire score and ABC score)
and using the median for non-parametric variables
(muscle function tests, functional tests and MNSI scores
for physical assessment).
After the confirmation of normality (Kolmogorov–
Smirnov test) and homoscedasticity (Levene’s test) of
parametric variables, a casewise two-way ANOVA for re-
peated measures, followed by a post hoc Newman–Keuls
correction, were used to verify the interaction effect of
Group x Time between baseline and after 12 weeks (p <
0.05). Comparisons between baseline and 12-week and
24-week follow-up were applied only to the IG, using
ANOVA for repeated measures or Friedman’s test to
verify whether patients who had received the interven-
tion returned to the baseline condition (p < 0.05). Non-
parametric data were compared using Mann–Whitney
tests for between-groups comparisons and Wilcoxon
tests for time effect comparisons (p < 0.05).
To describe the intervention effect, Cohen’s d coeffi-
cients were calculated, as well as mean or median differ-
ences, and its 95% confidence interval.
Role of the funding source
This study was funded by Sao Paulo Research Founda-
tion (FAPESP, process number 2011/19304-4) and by
Conselho Nacional de Desenvolvimento Científico e
Tecnológico (CNPq, process number 556374/2010-0).
The funding sources had no role in study design, data
collection, data analysis, interpretation of data, or writ-
ing of the trial report. The investigators had final re-
sponsibility in the decision to submit the report for
publication. The study was prospectively registered at
ClinicalTrials.gov (NCT01207284).
Results
The flowchart of the participants who completed or
abandoned the intervention and follow-up periods is de-
scribed in Figure 1. A total of 26 patients went into the
IG, and 29 into the CG. The participants did not differ
at baseline with respect to demographic, diabetes, and
foot characteristics (Table 1). For most of the loading
variables, mean velocity of COP displacement, and
muscle function, the groups did not differ at baseline,
except for PP at heel and medial forefoot (Table 2),
muscle function of extensor digitorum longus and bre-
vis, and toes extension on functional tests (Table 3).
Stride velocity (not included in the tables) was not sta-
tistically different between groups and assessments (group
effect: p = 0.57; time effect: p = 0.13; interaction effect: p =
0.61). Baseline velocity was 1.06 m/s (0.16 m/s) in the CG
and 1.09 m/s (0.14 m/s) in the IG; after 12 weeks it was
1.04 m/s (0.12 m/s) in the CG and 1.05 m/s (0.14 m/s) in
the IG. It neither differed in the follow-up assessment
(p = 0.08), when it reached 1.11 m/s (0.15 m/s).
Primary outcome and plantar pressure secondary
outcomes
Primary outcome
After the IG treatment period, an increase was observed
in peak pressure under the six foot areas and interaction
effects were found at midfoot (Table 2). Interestingly,
significant reductions appeared in the IG after the
follow-up period, especially under the midfoot and the
lateral forefoot.
Secondary outcomes
All in all, however, the intervention does not seem to
have yielded significant changes in plantar pressure dis-
tribution after 12 weeks. ANOVA two-way analysis
showed significant interaction effects for increase in out-
comes of TPP delay at the heel and anticipation at the
lateral forefoot (Table 2). Decrease in mean velocity of
COP displacement presented an interaction effect under
the midfoot and for total foot area (Table 2). Similarly to
the primary outcomes, PTI displayed interaction effects
at the midfoot (Table 2). Time effects were also observed
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Table 2 Mean, standard deviations and effects of intervention and follow-up on pressure variables
Time-to-peak pressure (% of stance phase)
Foot
areas
Control group Intervention group Intervention effect Follow-up effect
Baseline (a)
n = 29
12 weeks (b)
n = 29
Baseline (c)
n = 26
12 weeks (d)
n = 26
24 weeks (e)
n = 26
Effect sizeb-d
(Cohen’s d)
pa-b-c-d
(interaction)
Effect size
(Cohen’s d)
pc-d-e
Heel 17.9 (6.0) 18.1 (5.5) 17.4*‡ (5.4) 19.9*‡ (3.7) 17.7‡ (4.6) 0.3 (small) 0.03 0.5 (medium)c-d <0.01
0.1 (small)c-e
Midfoot 54.2 (14.3) 53.5 (13.6) 51.2 (16.6) 50.5 (15.2) 46.6 (12.7) 0.2 (small) 0.98 0.0 (small)c-d 0.12
0.3 (small)c-e
Medial
forefoot
81.9 (4.4) 82.1 (2.3) 82.0 (4.6) 81.6 (4.1) 81.7 (3.3) 0.1 (small) 0.52 0.1 (small)c-d 0.69
0.1 (small)c-e
Lateral
forefoot
80.3 (4.6) 80.7 (3.1) 82.0*¶ (3.7) 80.4* (3.5) 80.3 (3.2) 0.1 (small) 0.01 0.5 (medium)c-d <0.01
0.5 (medium)c-e
Hallux 85.8 (5.2) 85.6 (3.6) 85.0 (9.9) 83.4 (10.2) 84.8 (7.0) 0.3 (small) 0.18 0.2 (small)c-d 0.17
0.0 (small)c-e
Toes 83.5 (6.0) 83.1 (4.0) 83.2 (9.9) 81.5 (9.8) 82.5 (3.8) 0.2 (small) 0.36 0.2 (small)c-d 0.39
0.1 (small)c-e
Center of pressure – mean velocity (m/s)
Heel 0.4 (0.13) 0.4 (0.11) 0.4 (0.1) 0.4 (0.1) 0.4 (0.1) 0.1 (small) 0.30 0.1 (small)c-d 0.44
0.0 (small)c-e
Midfoot 0.4 (0.11) 0.5† (0.11) 0.5¶ (0.1) 0.4† (0.1) 0.4 (0.1) 0.4 (medium) 0.03 0.2 (small)c-d <0.01
0.5 (medium)c-e
Medial
forefoot
0.3 (0.09) 0.3 (0.07) 0.3# (0.1) 0.3 (0.1) 0.3# (0.1) 0.0 (small) 0.90 0.3 (small)c-d <0.01
0.6 (medium)c-e
Lateral
forefoot
0.3§ (0.17) 0.3 (0.11) 0.3¶ (0.1) 0.2§ (0.1) 0.2 (0.1) 0.3 (small) 0.58 0.4 (medium)c-d <0.01
0.6 (medium)c-e
Hallux 0.2 (0.23) 0.2|| (0.27) 0.1|| (0.2) 0.1|| (0.1) 0.2¶ (0.2) 0.5 (medium) 0.27 0.1 (small)c-d <0.01
0.4 (medium)c-e
Toes 0.1 (0.18) 0.1 (0.14) 0.1 (0.1) 0.1 (0.2) 0.1 (0.1) 0.2 (small) 0.95 0.1 (small)c-d 0.15
0.3 (small)c-e
Total 0.3 (0.05) 0.4 (0.04) 0.4 (0.1) 0.3 (0.0) 0.3 (0.0) 0.2 (small) 0.05 0.3 (small)c-d <0.001
0.7 (large)c-e
Pressure time integral (kPa.s)
Heel 79.1 (22.3) 79.1 (17.3) 81.0 (26.8) 87.6¶ (23.8) 77.9 (17.4) 0.4 (medium) 0.11 0.3 (small)c-d <0.01
0.1 (small)c-e
Midfoot 42.9* (20.9) 38.8* (20.6) 39.2 (14.7) 42.8 (25.4) 31.7¶ (9.1) 0.2 (small) 0.03 0.2 (small)c-d <0.01
0.6 (medium)c-e
Medial
forefoot
90.2 (28.3) 93.8 (20.5) 101.2 (29.9) 110.6†¶ (27.4) 103.7 (25.7) 0.7 (medium) 0.20 0.3 (small)c-d 0.01
0.1 (small)c-e
Lateral
forefoot
90.9 (24.6) 92.6 (20.5) 92.4 (22.4) 98.7¶ (24.6) 88.2 (19.7) 0.3 (small) 0.29 0.2 (small)c-d <0.01
0.2 (small)c-e
Hallux 48.6 (22.6) 50.6 (19.2) 47.2‡# (21.4) 55.1‡# (19.3) 49.5 (24.6) 0.2 (small) 0.22 0.4 (medium)c-d 0.03
0.1 (small)c-e
Toes 48.0 (24.1) 44.5 (22.6) 50.6 (22.9) 55.6 (26.9) 52.6 (21.4) 0.5 (medium) 0.16 0.2 (small)c-d 0.44
0.1 (small)c-e
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in the IG. TPP was anticipated at the lateral forefoot,
and delayed over the heel. After 12 weeks, there were in-
creases in PTI in all foot regions, significant in the med-
ial forefoot and hallux. The heel and toe areas displayed
a medium effect size, and also showed increased PTI
values after 12 weeks. An overall increasing tendency in
PP was found in all foot regions after 12 weeks, but the
increase was statistically significant only over the hallux.
As seen in Table 2, in the CG, PTI variations after
12 weeks of traditional medical care were not statistically
significant, and a reverse tendency was observed at the
midfoot and toes, as PTI decreased. A similar pattern was
observed for PP, with a reverse tendency at the midfoot and
toes. COP mean velocity also showed a non-significant re-
verse tendency over the heel, midfoot, and hallux.
Within the IG, comparisons between baseline,
12 weeks, and follow-up (ANOVA one-way) showed that
all outcomes returned to baseline, except for TPP at the
lateral forefoot (Table 2) and COP mean velocity
(Table 2). As observed for PP, interestingly, significant
PTI reductions under the midfoot and the lateral fore-
foot appeared in the IG after the follow-up period. It
seems that COP changes were maintained after the
follow-up period, and PP and PTI decreased again in the
follow-up period after an initial increase (end of inter-
vention), as if the foot-ankle complex had learnt how to
manage the more articulated roll-over process.
Secondary outcomes: kinetic and kinematic variables
There was an interaction effect for the total ankle range
of motion and for the ankle angle at the end of the
stance phase, where the CG showed decreasedresults
after 12 weeks (Table 4). In the IG, there was a time ef-
fect of decreased peak ankle extensor moment after
12 weeks of intervention, which remained different from
baseline until after follow-up.
Secondary outcomes: clinical variables
Compared to the baseline data, an expected significant
increase in muscle function was observed in the flexor
digitorum brevis, interosseous, tibialis anterior, and tri-
ceps surae in the IG after 12 weeks; the function of the
same muscles worsened significantly in the CG, except
for the triceps surae (Table 3). After the follow-up
period, the IG returned to baseline as for the flexor digi-
torum brevis, lumbricals, interosseous, and tibialis anter-
ior. The other muscles (extensor digitorum longus and
brevis, extensor hallucis longus and brevis, flexor hallu-
cis brevis, and triceps surae) also exhibited a worsened
function, but the differences between 12 weeks and the
follow-up period were not statistically significant.
All functional tests, except for ankle extension, showed
a difference between groups after 12 weeks, which points
to an improvement in the IG and a worsening in the CG
(Table 3). In intragroup comparisons, the IG improved
in all functional tests, while the CG showed a worsening
for toes flexion. For toes extension it should be noted
that both groups were different at baseline. At follow-up,
an improvement was found for toes and ankle extension,
but not for toes and ankle flexion.
As for the MNSI questionnaire, foot physical examin-
ation and ABC score (Table 3), there was no significant
Table 2 Mean, standard deviations and effects of intervention and follow-up on pressure variables (Continued)
Peak pressure (kPa)
Heel 293.6 (68.4) 305.4 (64.3) 314.1 (88.0) 324.1 (77.6) 293.4 (64.4) 0.3 (small) 0.91 0.1 (small)c-d 0.01
0.3 (small)c-e
Midfoot 125.1 (63.6) 113.1 (61.3) 119.5 (43.7) 122.3 (46.5) 91.7¶ (21.4) 0.2 (small) 0.08 0.1 (small)c-d <0.001
0.8 (large)c-e
Medial
forefoot
313.4§ (101.4) 328.7 (77.2) 356.3§ (100.1) 370.8§ (89.4) 350.5 (81.9) 0.5 (medium) 0.95 0.2 (small)c-d 0.16
0.1 (small)c-e
Lateral
forefoot
297.9 (83.9) 307.1 (72.5) 316.8 (79.5) 318.5 (56.4) 291.1¶ (65.8) 0.2 (small) 0.59 0.0 (small)c-d <0.01
0.4 (large)c-e
Hallux 214.8 (69.2) 229.7 (85.1) 206.9‡ (96.8) 235.2‡¶ (84.4) 212.1 (95.4) 0.1 (small) 0.46 0.1 (small)c-d 0.03
0.0 (small)c-e
Toes 180.6 (99.6) 173.9 (93.2) 187.1 (84.2) 199.0 (94.8) 185.3 (73.0) 0.3 (small) 0.40 0.16 (small)c-d 0.53
0.01 (small)c-e
*different conditions between each other (interaction and time effect p = 0.01).
†condition b is different from d (interaction effect).
‡conditions c d, and e are different from one another in follow-up comparisons.
¶the different condition from the others in follow-up comparisons (p < 0.01).
§condition a is different from d (time effect, p = 0.04).
||condition b is different from c and d (group effect, p < 0.01).
#condition c is different from e in follow-up comparisons (p < 0.01).
Letters a, b, c, d and e represent the groups conditions.
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Table 3 Intervention and follow-up effects of clinical assessment
Diabetic polineuropathy clinical assessment
Instrument Control Group Intervention Group Intervention effect Follow-up effect
Baseline (a)
n = 29
12 weeks (b)
n = 29
Baseline (c)
n = 26
12 weeks (d)
n = 26
24 weeks (e)
n = 26
Effect size or median
difference (CI 95%)b-d
Effect size or median
difference (CI 95%)b-d
MNSI questionnaire
(score)a
6 (3) 6 (3) 6¶§ (2) 4¶ (3) 4 (2) 0.52 (medium) 0.54 (medium)c-d
0.54 (medium)c-e
MNSI physical
assessment (score)b
4.5 (3; 6.5) 5.5 (2.5; 7) 4.5 (3.0; 6.5) 4.0§ (4.0; 5.0) 5.0§ (5.0; 5.5) −1.5 [−2.8 a −0.2] −0.5 [−1.7 a 1.7]c-d
0.5 [−0.7 a 1.7]c-e
ABC questionnaire
(% of confidence)c
78 (18) 78 (19) 84 (16) 86§ (8) 89§ (8) 0.50 (medium) 0.34 (small)c-d
0.21 (small)c-e
Muscle functiond
Extensor digitorum
longus and brevis
3.5* 4.0 4.0*§ 4.0 4.0§ 0.0 [0.0 to 0.0] 0.0 [0.0 to 0.0]c-d
(3.0; 4.0) (3.0;5.0) (3.3;5.0) (4.0;4.0) (3.0;4.0) 0.0 [0.0 to 0.0]c-e
Extensor hallucis
longus and brevis
4.0 4.0 4.0 4.0 4.0 0.0 [0.0 to 0.0] 0.0 [−0.5 to 0.5]c-d
(4.0;5.0) (4.0;5.0) (4.0;5.0) (4.0;5.0) (4.0;4.0) 0.0 [−0.5 to 0.5]c-e
Flexor digitorum brevis 4.0† 4.0†‡ 4.0 5.0‡ 4.0 −1.0 [−1.0 to −1.0] 0.0 [−0.5 to 0.5]c-d
(4.0;5.0) (3.0;5.0) (3.0;5.0) (4.0;5.0) (4.0;4.0) 0.0 [−0.5 to 0.5]c-e
Flexor hallucis brevis 4.0 4.0 4.0 4.0 4.0 0.0 [0.0 to 0.0] 0.0 [0.0 to 0.0]c-d
(3.0;5.0) (3.3;4.8) (4.0;5.0) (4.0;5.0) (4.0;4.0) 0.0 [0.0 to 0.0]c-e
Lumbrical 4.0† 3.0† 4.0 4.0§ 3.5§ −1.0 [−1.5 to -.05] 0.0 [−0.9 to 0.9]c-d
(3.0;5.0) (2.0;5.0) (2.0;5.0) (3.0;4.8) (2.3;4.0) 0.5 [−0.4 to 0.4]c-e
Interosseous 3.5 3.0‡ 4.0 4.0‡§ 3.0§ −1.0 [−1.5 to −0.5] 0.0 [0.5 to 1.5]c-d
(2.0;4.0) (2.0;4.0) (2.0;5.0) (3.0;4.0) (3.0;3.0) 1.0 [0.5 to 1.5]c-e
Tibialis anterior 4.5 4.0‡ 4.0 5.0‡ 4.0 −1.0 [−1.0 to −1.0] 0.0 [−0.5 to 0.5]c-d
(3.0;5.0) (4.0;5.0) (4.0;5.0) (4.0;5.0) (4.0;4.0) 0.0 [−0.5 to 0.5]c-e
Triceps surae 5.0 5.0 5.0¶ 5.0¶ 5.0 0.0 [0.0 to 0.0] 0.0 [0.0 to 0.0]c-d
(4.0;5.0) (4.0;5.0) (4.0;5.0) (5.0;5.0) (4.0;5.0) 0.0 [0.0 to 0.0]c-e
Functional testse
Ankle flexion 3.5 3.0‡ 4.0¶ 4.0‡¶# 3.0 1.0 [0.5 a 1.5] 0.0 [−0.4 a 2.4]c-d
(1.0;4.0) (1.0;4.0) (1.0;4.0) (3.0;4.0) (1.0;4.0) 1.0 [−0.4 a 2.4]c-e
Ankle extension 4.0† 4.0† 4.0¶§ 4.0¶ 4.0§ 0.0 [0.0 a 0.0] 0.0 [0.0 a 0.0]c-d
(4.0;4.0) (4.0;4.0) (4.0;4.0) (4.0;4.0) (4.0;4.0) 0.0 [0.0 a 0.0]c-e
Toes flexion 4.0 3.5‡ 4.0¶# 4.0‡¶ 4.0 0.5 [0.0 a 1.0] 0.0 [−0.5 a 0.5]c-d
(3.0;4.0) (3.0;4.0) (3.0;4.0) (4.0;4.0) (4.0;4.0) 0.0 [−0.5 a 0.5]c-e
Toes extension 4.0* 4.0‡ 4.0*¶ 4.0‡¶§ 4.0§ 0.0 [0.0 a 0.0] 0.0 [0.0 a 0.0]c-d
(3.3;4.0) (4.0;4.0) (4.0;4.0) (4.0;4.0) (4.0;4.0) 0.0 [0.0 a 0.0]c-e
*differences between baselines (p < 0.05).
†differences between baseline and 12 weeks for the control group (p < 0.05).
‡two different conditions from each other (p < 0.05).
§different conditions from each other between follow-up comparisons (p < 0.05).
¶differences between baseline and 12 weeks for the intervention group (p < 0.05).
amean and standard deviation; maximum score of 13 (symptoms of DPN).
bmedian and interquartile interval; maximum score of 10 (tactile and vibration sensitivity, calcaneal reflex and foot inspection).
cmean and standard deviation; maximum of 100% (% of confidence referred by the patients).
dmedian and interquartile interval; muscle function test gradation (Kendall et al., 2005):
5:holds test position against maximal resistance.
4:holds test position against moderate resistance.
3:holds test position against gravity.
2:able to move through full ROM with gravity eliminated.
1:no visible movement, palpable or observed tendon prominence/flicker contraction.
0:no palpable or observable muscle contraction.
eClassification of foot function (Palmer and Epler, 1990):
4:normal functionality.
3:reasonable functionality.
2:little functionality.
1:absent functionality.
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difference between groups in any of the assessments. In
the IG , there was a reduction of 2 points in the MNSI
questionnaire, with a medium effect size, which
remained after the 12 week follow-up. This means that
there was an improvement in the clinical condition of
the patients. A reduction was also observed of the score
for the physical examination of the feet at the follow-up
assessment as compared to the corresponding scores
after 12 weeks, but there was a significant improvement
in the ABC score.
Discussion
As a global interpretation, the results suggest that the
proposed physiotherapy intervention in patients with
DPN modestly changed the foot rollover to a more
physiological process, supported by some improvement
in dynamic pressure distribution, improvement of ankle
extension moment and a better functional condition of
the foot and ankle muscles.
Primary outcomes
The expected reduction in forefoot PP was not observed
at the end of the treatment, although our findings sug-
gest a better foot rollover; rather, forefoot PP was signifi-
cantly reduced after the follow up period, as was also
noticed for midfoot PP. To better understand whether
changes in the primary outcomes have to be interpreted
as a sign of improvement or worsening of DNP overall
foot function, intervention effects are hereby discussed
in more detail, with reference to all the investigated vari-
ables grouped as biomechanical and clinical variables,
and with respect to the main temporal phases of the
rollover process.
Effects of the intervention on biomechanical variables
(plantar pressure, kinematic and kinetic variables)
In the heel strike phase, two important findings were ob-
served. First, the intervention provided a delay in TPP at
the heel (interaction effect), which means a lower rate of
loading and better shock absorption in this gait phase.
The second important change was the increase in PTI
over the heel (medium effect). Since PP over the heel
did not increase, the higher PTI was likely due to the
delay in TPP occurrence and to a longer stance over this
foot area. Since the protocol included exercises that in-
volved proximal muscles as well (e.g. walking exercises),
reduced impact at heel strike can be a consequence of
the improved performance of hip flexors, hamstrings,
and quadriceps [36], which were trained during the
walking exercises. Softening of the heel impact is a posi-
tive outcome because a proper positioning of the heel at
the initial ground/foot contact influences the positioning
of the next foot segments during the midstance and pro-
pulsion phases [8,10] and ensures an adequate foot roll-
over process.
In the midstance phase, the IG showed a slower COP
trajectory at the midfoot and unchanged PP and PTI
after the intervention., while the CG showed a decrease
in midfoot PTI. DPN patients are known to poorly con-
trol foot-flattening and midstance phases , mainly owing
to the impaired eccentric function of the tibialis anterior,
which is responsible for decelerating the forefoot until it
touches the floor [17,18,45]. Besides, DPN patients have
straight COP trajectory from the heel toward the medial
forefoot, with shorter COP excursion in the medial-
lateral direction [7]. Midfoot COP, PTI and PP results
suggest a better control of the foot-flattening and mid-
stance phases. The improvement in the foot-flattening
phase after the intervention is also supported by the
Table 4 Mean, standard deviation and effects of intervention and follow-up on kinetics and kinematics of ankle
Kinetic and kinematic
Control group Intervention group Intervention effect Follow-up effect
Baseline
(a) n = 29
12 weeks
(b) n = 29
Baseline
(c) n = 26
12 weeks
(d) n = 26
24 weeks
(e) n = 26
Effect size-b-d
(Cohen’s d)
pa-b-c-d
(interaction)
Efect size
(Cohen’s d)
pc-d-e
Sagittal ankle range
of motion of stance phase (°)
22.5† (3.5) 18.9† (4.1) 20.8 (4.9) 20.8 (3.3) 19.6 (2.1) 0.53 (medium) 0.001 0.02 (small)c-d 0.14
0.31 (small)c-e
Sagittal ankle angle at the
end of propulsion phase (°)
−8.4† (5.8) −5.5† (3.9) −7.5 (6.4) −7.5 (4.6) −7.8 (4.2) 0.46 (medium) 0.02 (small)c-d 0.91
0.05 (small)c-e
Sagittal peak of extensor
moment of ankle ~20%
stance phase (%BW.h)
−0.8 (0.2) −0.7 (0.3) −0.9‡¶ (0.4) −0.7‡ (0.3) −0.7¶ (0.3) 0.17 (small) 0.63 0.37 (small)c-d 0.02
0.45 (medium)c-e
Sagittal peak of flexor
moment of ankle ~80%
stance phase (%BW.h)
8.1 (0.7) 8.2 (0.4) 7.9 (0.9) 8.2 (0.9) 8.3 (0.4) 0.09 (small) 0.63 0.25 (small)c-d 0.17
0.45 (medium)c-e
†condition a is different from b (interaction and time effects, p < 0.001).
‡condition c is different from d (time effect, p < 0.01).
¶condition c is different from e in follow-up comparisons.
Letters a, b, c, d and e represent the groups conditions.
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decreased ankle extensor moment, the improvement in
the ankle dorsiflexion (functional tests) and in the func-
tion of the tibialis anterior (manual muscle function
test).
At baseline, the TPP of the medial and lateral forefoot
occurs simultaneously in both groups, which denotes an
altered forefoot rollover, as the lateral region should
make ground contact earlier than the medial area
[10,11]. The anticipation of TPP at the lateral forefoot
after 12 weeks of training (interaction effect) indicates a
more physiological foot rollover, suggesting an improve-
ment in foot mobility in the transverse plane. As demon-
strated by Rao et al. [8], patients with DPN exhibit a loss
of pronation and supination of the foot, which is impera-
tive to allow for a proper loading transfer from the heel
to the lateral forefoot. A limitation of the present study
is that the mobility of the small foot joints could not be
assessed. To confirm the hypothesized improvement in
foot mobility in the transverse plane, further studies
should address intrinsic foot mobility.
Considering again the primary outcome (PP) related to
the forefoot areas, there was a group and time effect
after 12 weeks, but no interaction effect, and both
groups were different at baseline. Basically, the results
are inconclusive as whether the proposed intervention
did induce a relevant change in loading over forefoot PP.
In any case, DPN prevention should not aim at merely
reducing PP over the forefoot, mostly because this is not
an optimal variable for describing time changes during
the whole process of foot rollover. It only represents ver-
tical loading during a very short time of the stance
phase. Obviously, attention must be paid to keep plantar
pressures under the proper risk threshold, although no
cutoff value consensus for ulcer risk has been estab-
lished yet [45].
The toes and hallux are known to have reduced par-
ticipation in the walking of patients with DPN, reflected
by a shorter COP excursion in the anteroposterior direc-
tion [7]. This is usually attributed to foot and ankle joint
restrictions [3,8] and marked weakness of intrinsic foot
muscles [19]. If the toes and hallux are no longer active
due to DPN, the forefoot has to take over the function
of propelling the body forward during walking and be-
comes overloaded [10], which has been associated with
ulcer formation. The increased PP and PTI over the hal-
lux, as well as the medium effect of the increase in PTI
over the toes, were highly relevant to the foot function
during the rollover process. The stretching exercises and
walk training were efficient in improving hallux and toe
mobility and function, reflected in the redistribution of
plantar pressure. In addition, the increase in the score
for the interosseous muscle function reasonably indi-
cates a positive effect of the proposed strengthening ex-
ercises on toe function.
Effects of the intervention on clinical variables
All in all, the foot and ankle complex as assessed by clin-
ical tests (manual muscle function and repetition of
movements) showed an improvement of the intrinsic
and extrinsic muscle function, especially in ankle dorsi-
flexion (tibialis anterior), toes flexion (flexor digitorum
brevis) and of interosseous muscles. The main differ-
ences between the groups were observed after 12 weeks.
Ankle flexion and toes movements are expected to be-
come impaired throughout the course of the disease.
Training these functions preventatively may slow down
the prognosis of the diabetes chronic complications. The
gain in these functions can explain the changes in the
pressure variables in foot rollover observed after
12 weeks of intervention, such as the decreased COP
velocity at midfoot, the increased PTI in toes area, and
the better control of forefoot contact.
The signs and symptoms of DPN had changed after
the intervention (MNSI questionnaire score). The IG re-
ferred fewer symptoms after the intervention compared
to the baseline condition. There was a slight worsening
in the score of the physical examination of the feet in
the control group after 12 weeks, and a small difference
(1.5 points) between both groups after 12 weeks. This
difference may indicate a worsening of tactile or vibra-
tion perceptions. Since twelve weeks is a relatively short
period for structural deformities to set in, this change is
likely to have occurred at the somatosensory level.
Limitations and clinical implications
The main limitation of this clinical trial is the lack of
follow-up for the CG. Therefore, follow-up results could
not be compared between CG and IG. Besides, there
was no control over patients’ compliance regarding
home exercises during this period.
Previous studies do not describe the foot rollover
changes after such a specific set of exercises for foot and
ankle [24-27]. Usually, attention is mostly given to PP
and PTI reduction as a target to reduce the risk of ulcer-
ation, but these variables should be analyzed together
with several other risk factors [4,5,36]. This study also
showed time-related changes during the complex task of
foot rollover, among the most representative variables of
foot loading transfer and management, and that can help
better interpret the changes in PP and PTI variables.
The study population sample was composed mostly of
non-severe neuropathic patients, i.e., subjects who have
not lost all their sensitivity and muscle functions. The
protocol described herein can be applied to every patient
with or without diabetic neuropathy, regardless of the
stage of the disease, the only exception being patients
with tissue damage at the time of the exercise. However,
the effect of this intervention has not yet been studied in
severe neuropathic patients, with or without previous
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ulceration. Before implementing this type of interven-
tion, a risk analysis is recommended to verify patient
safety and compatibility of the exercise therapy with on-
going treatment.
Lastly, the crucial role of preventive actions in neuro-
pathic patients should be highlighted, as complications
in muscles and joints occur over the long term, and it is
of great importance to preserve and maintain their in-
tegrity. For incipient and moderately impaired patients
with DPN, the proposed exercises are easy to perform at
home, as opposed to general purpose exercises that need
supervision (24,27). Stronger patient motivation and re-
mote monitoring would certainly help patients reach
their goals. Until now, most therapies have been applied
only after ulceration and amputation, with relative suc-
cess; only a few have been studied before such events.
Conclusion
The combination of stretching, strengthening, and func-
tional foot and ankle exercises provided modest changes
in foot rollover. Pressure redistribution occurred in foot
areas (heel, lateral forefoot, hallux, and toes) that are
known to exhibit reduced participation in patients with
DPN [7]. The lower velocity of COP displacement, with-
out an increase in walking velocity or contact time, also
indicates a dynamic loading pattern that shows better in-
volvement of the whole foot. This change toward a more
physiological pattern, together with foot and ankle func-
tion improvement, entails a better foot-to-floor inter-
action. Considering that DPN is a long-term disease,
preventive actions such as this exercise protocol can be
prescribed for this population as a complementary inter-
vention. To maintain the obtained benefits longer, the
periodic repetition of the intervention is recommended.
Additional files
Additional file 1: Table S1. Description, execution, and progression
parameters of the exercises included in the intervention protocol.
Additional file 2: Figure S2. Online only Figure 1 Example of exercises
for (a) passive stretching of flexors and extensors of toes and hallux and
(b) strengthening of ankle inversors, eversors and flexors. Online only
Figure 2 – Examples of exercises for (a) balance training in unstable
surface and (b) stretching of triceps surae. Online only Figure 3 –
Example of exercises for (a) strengthening of tibialis anterior and triceps
surae and (b) strengthening of intrinsic foot muscles using different
materials.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
ICNS, CDS, RW, ACP and RHH were responsible for designing the study. CDS,
CG, LPC and MKB were responsible for data analysis. All authors were
responsible for discussing and interpreting the results and writing the final
version to be published. ICNS, CDS, and ACP acted as trial coordinators. All
the authors have approved the final manuscript. All authors read and
approved the final manuscript.
Acknowledgements
We acknowledge the Centro de Saúde-Escola Samuel Pessoa and Associação
Nacional de Assistência ao Diabético for providing the patients. Ms. Monica
Brocco for the linguistic editing of the manuscript.
Author details
1Physical Therapy, Speech and Occupational Therapy Dept, School of
Medicine, University of São Paulo, 51, Cidade Universitária, São Paulo, SP,
Brazil. 2Department of Technology and Health, Italian National Institute of
Health, Rome, Italy.
Received: 1 November 2013 Accepted: 16 April 2014
Published: 27 April 2014
References
1. Veves A, Murray HJ, Young MJ, Boulton AJ: The risk of foot ulceration in
diabetic patients with high foot pressure: a prospective study.
Diabetologia 1992, 35(7):660–663.
2. Allet L, Armand S, Golay A, Monnin D, de Bie RA, de Bruin ED: Gait
characteristics of diabetic patients: a systematic review. Diabetes Metab
Res Rev 2008, 24(3):173–191.
3. Rao S, Saltzman CL, Yack HJ: Relationships between segmental foot
mobility and plantar loading in individuals with and without diabetes
and neuropathy. Gait Posture 2010, 31(2):251–255.
4. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A: Role of
neuropathy and high foot pressures in diabetic foot ulceration.
Diabetes Care 1998, 21(10):1714–1719.
5. Mueller MJ, Diamond JE, Delitto A, Sinacore DR: Insensitivity, limited joint
mobility, and plantar ulcers in patients with diabetes mellitus.
Phys Ther 1989, 69(6):453–459. discussion 459–462.
6. Stess RM, Jensen SR, Mirmiran R: The role of dynamic plantar pressures in
diabetic foot ulcers. Diabetes Care 1997, 20(5):855–858.
7. Giacomozzi C, Caselli A, Macellari V, Giurato L, Lardieri L, Uccioli L: Walking
strategy in diabetic patients with peripheral neuropathy.
Diabetes Care 2002, 25(8):1451–1457.
8. Rao S, Saltzman C, Yack HJ: Segmental foot mobility in individuals with
and without diabetes and neuropathy. Clin Biomech (Bristol, Avon) 2007,
22(4):464–471.
9. Sacco IC, Hamamoto AN, Gomes AA, Onodera AN, Hirata RP, Hennig EM:
Role of ankle mobility in foot rollover during gait in individuals with
diabetic neuropathy. Clin Biomech (Bristol, Avon) 2009, 24(8):687–692.
10. Saltzman CL, Nawoczenski DA: Complexities of foot architecture as a base
of support. J Orthop Sports Phys Ther 1995, 21(6):354–360.
11. McPoil TG, Knecht HG: Biomechanics of the foot in walking: a function
approach. J Orthop Sports Phys Ther 1985, 7(2):69–72.
12. Kjaer M: Role of extracellular matrix in adaptation of tendon and skeletal
muscle to mechanical loading. Physiol Rev 2004, 84(2):649–698.
13. Goldin A, Beckman JA, Schmidt AM, Creager MA: Advanced glycation end
products: sparking the development of diabetic vascular injury.
Circulation 2006, 114(6):597–605.
14. Fiolkowski P, Brunt D, Bishop M, Woo R, Horodyski M: Intrinsic pedal
musculature support of the medial longitudinal arch: an
electromyography study. J Foot Ankle Surg 2003, 42(6):327–333.
15. Headlee DL, Leonard JL, Hart JM, Ingersoll CD, Hertel J: Fatigue of the
plantar intrinsic foot muscles increases navicular drop. J Electromyogr
Kinesiol 2008, 18(3):420–425.
16. van Schie CH: A review of the biomechanics of the diabetic foot.
Int J Low Extrem Wounds 2005, 4(3):160–170.
17. Abboud RJ, Rowley DI, Newton RW: Lower limb muscle dysfunction may
contribute to foot ulceration in diabetic patients. Clin Biomech
(Bristol, Avon) 2000, 15(1):37–45.
18. Sacco IC, Amadio AC: Influence of the diabetic neuropathy on the
behavior of electromyographic and sensorial responses in treadmill gait.
Clin Biomech (Bristol, Avon) 2003, 18(5):426–434.
19. Greenman RL, Khaodhiar L, Lima C, Dinh T, Giurini JM, Veves A: Foot small
muscle atrophy is present before the detection of clinical neuropathy.
Diabetes Care 2005, 28(6):1425–1430.
20. Andreassen CS, Jakobsen J, Andersen H: Muscle weakness: a progressive
late complication in diabetic distal symmetric polyneuropathy.
Diabetes 2006, 55(3):806–812.
Sartor et al. BMC Musculoskeletal Disorders 2014, 15:137 Page 12 of 13
http://www.biomedcentral.com/1471-2474/15/137
21. Bus SA, Valk GD, van Deursen RW, Armstrong DG, Caravaggi C, Hlavácek P,
Bakker K, Cavanagh PR: The effectiveness of footwear and offloading
interventions to prevent and heal foot ulcers and reduce plantar
pressure in diabetes: a systematic review. Diabetes Metab Res Rev 2008,
24(Suppl 1):S162–180.
22. Cavanagh PR, Bus SA: Off-loading the diabetic foot for ulcer prevention
and healing. Plast Reconstr Surg 2011, 127(Suppl 1):248S–256S.
23. Waaijman R, Keukenkamp R, De Haart M, Polomski WP, Nollet F, Bus SA:
Adherence to Wearing Prescription Custom-Made Footwear in Patients
With Diabetes at High Risk for Plantar Foot Ulceration. Diabetes Care
2013, 36(6):1613–8.
24. Pataky Z, de León Rodriguez D, Allet L, Golay A, Assal M, Assal JP, Hauert
CA: Biofeedback for foot offloading in diabetic patients with peripheral
neuropathy. Diabet Med 2010, 27(1):61–64.
25. Richardson JK, Sandman D, Vela S: A focused exercise regimen improves
clinical measures of balance in patients with peripheral neuropathy.
Arch Phys Med Rehabil 2001, 82(2):205–209.
26. Goldsmith JR, Lidtke RH, Shott S: The effects of range-of-motion therapy
on the plantar pressures of patients with diabetes mellitus. J Am Podiatr
Med Assoc 2002, 92(9):483–490.
27. York RM, Perell-Gerson KL, Barr M, Durham J, Roper JM: Motor learning of a
gait pattern to reduce forefoot plantar pressures in individuals with
diabetic peripheral neuropathy. PM R 2009, 1(5):434–441.
28. Sartor CD, Watari R, Passaro AC, Picon AP, Hasue RH, Sacco ICN: Effects of a
combined strengthening, stretching and functional training program
versus usual-care on gait biomechanics and foot function for diabetic
neuropathy: a randomized controlled trial. BMC Musculoskelet Disord 2012,
13:36.
29. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A: Screening
techniques to identify people at high risk for diabetic foot ulceration: a
prospective multicenter trial. Diabetes Care 2000, 23(5):606–611.
30. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G,
Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P, Toronto Diabetic
Neuropathy Expert Group: Diabetic neuropathies: update on definitions,
diagnostic criteria, estimation of severity, and treatments. Diabetes Care
2010, 33(10):2285–2293.
31. Fernando M, Crowther R, Lazzarini P, Sangla K, Cunningham M, Buttner P,
Golledge J: Biomechanical characteristics of peripheral diabetic
neuropathy: A systematic review and meta-analysis of findings from the
gait cycle, muscle activity and dynamic barefoot plantar pressure.
Clin Biomech (Bristol, Avon) 2013, 28(8):831–45.
32. Michigan Neuropathy Screening Instrument. http://www.med.umich.edu/
mdrtc/profs/survey.html#mnsi.
33. Bland M: Clinstat software; 2009. [Available at http://www-users.york.ac.uk/~mb55/
soft/soft.htm]
34. Bakker K, Apelqvist J, Schaper NC, Board IWGoDFE: Practical guidelines on
the management and prevention of the diabetic foot 2011.
Diabetes Metab Res Rev 2012, 28(1):225–231.
35. Powell LE, Myers AM: The Activities-specific Balance Confidence (ABC)
Scale. J Gerontol A Biol Sci Med Sci 1995, 50A(1):M28–34.
36. Winter D: The Biomechanics and Motor Control of Human Gait: Normal,
Elderly and Pathological. Waterloo, CA: University of Waterloo Press; 1991.
37. Campbell K: Data acquisition and Analysis. In ASME International
Computers in Engineering Conference and Exhibition. New York, NY: 1987.
38. Trombini-Souza F, Kimura A, Ribeiro AP, Butugan M, Akashi P, Pássaro AC,
Arnone AC, Sacco IC: Inexpensive footwear decreases joint loading in
elderly women with knee osteoarthritis. Gait Posture 2011, 34(1):126–130.
39. Dempster WT, Gaughran GRL, Dempster WT, Gaughran GRL: Property of
body segments based on size and weigth. Am J Anat 1967, 120(1):33–54.
40. Kendall F, McCreary E, Provance P, Rodgers M, Romani W: Testing and
Function with Posture and Pain. New York, USA: Lippinicott Williams &
Wilkins; 2005.
41. van Schie CH, Vermigli C, Carrington AL, Boulton A: Muscle weakness and
foot deformities in diabetes: relationship to neuropathy and foot
ulceration in caucasian diabetic men. Diabetes Care 2004, 27(7):1668–1673.
42. Bacarin TA, Sacco IC, Hennig EM: Plantar pressure distribution patterns
during gait in diabetic neuropathy patients with a history of foot ulcers.
Clinics (Sao Paulo) 2009, 64(2):113–120.
43. Haukoos JS, Newgard CD: Advanced statistics: missing data in clinical
research–part 1: an introduction and conceptual framework. Acad Emerg
Med 2007, 14(7):662–668.
44. Twisk J, de Vente W: Attrition in longitudinal studies. How to deal with
missing data. J Clin Epidemiol 2002, 55(4):329–337.
45. Armstrong DG, Peters EJ, Athanasiou KA, Lavery LA: Is there a critical level
of plantar foot pressure to identify patients at risk for neuropathic foot
ulceration? J Foot Ankle Surg 1998, 37(4):303–307.
doi:10.1186/1471-2474-15-137
Cite this article as: Sartor et al.: Effects of strengthening, stretching and
functional training on foot function in patients with diabetic neuropathy:
results of a randomized controlled trial. BMC Musculoskeletal Disorders
2014 15:137.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sartor et al. BMC Musculoskeletal Disorders 2014, 15:137 Page 13 of 13
http://www.biomedcentral.com/1471-2474/15/137
